Navigation Links
Accelr8 to Hold 2012 Annual Meeting of Shareholders; Product Development Continues with Launch Expected in 2015
Date:12/11/2012

DENVER, Dec. 11, 2012 /PRNewswire/ -- Accelr8 Technology Corporation (NYSE MKT: AXK) will hold its 2012 Annual Meeting of Shareholders (the "Annual Meeting") at 2:30 p.m., local time, on Wednesday, December 12, 2012, at the Warwick Hotel Denver, 1776 Grant Street, Denver, Colorado 80203.

Progress towards the company's IVD product launch continues, with management expecting to be in development through 2014, launching in 2015, with additional clinical trials continuing through 2016.

About Accelr8

Accelr8 Technology Corporation (www.accelr8.com) is focused on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.  The Company's BACcel™ platform utilizes a proprietary culture-free process with both genomic and phenotypic detection technologies that decrease time to result while maintaining high sensitivity and specificity. 

Disclaimer Regarding Forward-Looking Statements

Certain statements in this news release may be "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Statements regarding future prospects and developments are based upon current expectations and involve certain risks and uncertainties that could cause actual results and developments to differ materially from the forward-looking statement, including those detailed in the Company's filings with the SEC.  The Company does not undertake an obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events.


'/>"/>
SOURCE Accelr8 Technology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Accelr8 Appoints Steve Reichling Chief Financial Officer
2. MiMedx Group to Present at the 6th Annual OneMedForum
3. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
4. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
5. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
6. Thoratec Presentation At Oppenheimer 23rd Annual Healthcare Conference To Be Webcast
7. Henry Schein To Present At The Oppenheimer 23rd Annual Healthcare Conference
8. PROLOR Biotech To Present Preclinical Data On Its Long-Acting Clotting Factor Vlla At 2012 ASH Annual Meeting
9. Accuray Incorporated to Speak at 23rd Annual Oppenheimer Healthcare Conference
10. HeartWare Presentation at the Oppenheimer 23rd Annual Healthcare Conference to be Webcast
11. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017  Market Research Future published a ... Devices Market is expected to reach USD 33.6 million during the ... Market Highlights ... The Global Endoscopy Devices Market has been examined as a swiftly ... there is huge demand for endoscopy device in various regions.  The ...
(Date:1/17/2017)... Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential ... or the "Company") (NASDAQ: ANTH ). Such investors ... by visiting the firm,s site: www.bgandg.com/anth .   ... and/or directors have violated Sections 10(b) and 20(a) of the ... ...
(Date:1/17/2017)... 17, 2017  In a letter to President-elect ... Jenkins outlines AARP,s priorities for Americans age 50 ... access to affordable health care coverage, and lowering the ... Jenkins writes to President-elect Trump that "Our nearly 38 ... on you to protect their Medicare and Social Security ...
Breaking Medicine Technology:
(Date:1/17/2017)... Elk Grove Village, IL (PRWEB) , ... January ... ... products for musicians and music enthusiasts at the National Association of Music Merchants ... California, January 19 – 22, 2017. , Etymotic’s ER•4® has long been the ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... Medical Center joined the Peoples Health network on Dec. 1, 2016. Peoples ... , “JenCare Senior Medical Center is an exciting addition to our provider network, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Wettstein Agencies, a Denver area ... professionals throughout central Colorado, is joining local nonprofit Aurora Warms The Night to ... Night organization is committed to breaking the cycle of homelessness and poverty affecting ...
(Date:1/17/2017)... ... January 17, 2017 , ... The Sharie Withers Agency, ... announced the latest beneficiary of their thriving community involvement program. The current campaign ... fulfilling the dreams of terminally ill patients. Donations to this worthy cause may ...
(Date:1/16/2017)... (PRWEB) , ... January 17, 2017 , ... ... Au Bon Pain, an internationally recognized leader in the fast-casual category, announces a ... such as the Good Egg Breakfast Sandwich, Turkey Mash-Up Sandwich, Cranberry Crunch & ...
Breaking Medicine News(10 mins):